Gene expression profiling of breast cancer cell lines in response to soy isoflavones using a pangenomic microarray approach

OMICS A Journal of Integrative Biology

Volumn 14, Issue 3, 2010, Pages 231-238

  Satih, Samir ^a,b   Chalabi, Nasséra ^a,b   Rabiau, Nadège ^a,c   Bosviel, Rémy ^a,b   Fontana, Luc ^b,d   Bignon, Yves Jean ^a,b   Bernard Gallon, Dominique J ^a,b  

^a CENTRE JEAN PERRIN   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c Soluscience Biopôle Clermont Limagne   (France)

^d UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; ESTROGEN; GENISTEIN; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; XENOBIOTIC AGENT;

AMINO ACID SEQUENCE; ARTICLE; BIODEGRADATION; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL COMMUNICATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; GENE CLUSTER; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; HUMAN CELL; LIPID METABOLISM; MICROARRAY ANALYSIS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHARMACOGENOMICS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELLS, CULTURED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; GENOME, HUMAN; HUMANS; ISOFLAVONES; MICROARRAY ANALYSIS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PHYTOESTROGENS;

EID: 77954212241     PISSN: 15362310     EISSN: None     Source Type: Journal    
DOI: 10.1089/omi.2009.0124     Document Type: Article

References (40)

1. Azios, N.G., Krishnamoorthy, L., Harris, M., Cubano, L.A., Cammer. M., and Dharmawardhane, S.F. (2007). Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells. Neoplasia 9, 147-158.
2. Cailleau, R., Young, R., Olive, M., and Reeves, W.J., Jr. (1974). Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53, 661-674.
3. Chalabi, N., Delort, L., Le Corre, L., Satih, S., Bignon, Y.J., and Bernard-Gallon, D. (2006). Gene signature of breast cancer cell lines treated with lycopene. Pharmacogenomics 7, 663-672.
4. Chalabi, N., Satih, S., Delort, L., Bignon, Y.J., and Bernard-Gallon, D.J. (2007). Expression profiling by whole-genome microarray hybridization reveals differential gene expression in breast cancer cell lines after lycopene exposure. Biochim Biophys Acta 1769, 124-130.
5. Dertsiz, L., Ozbilim, G., Kayisli, Y., Gokhan, G.A., Demircan, A., and Kayisli, U.A. (2005). Differential expression of VASP in normal lung tissue and lung adenocarcinomas. Thorax 60, 576-581.
6. Dip, R., Lenz, S., Antignac, J.P., Le Bizec, B., Gmuender, H., and Naegeli, H. (2008). Global gene expression profiles induced by phytoestrogens in human breast cancer cells. Endocr Relat Cancer 15, 161-173.
7. Divya, C.S., and Pillai, M.R. (2006). Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol Carcinog 45, 320-332.
8. Edwards, D. (2003). Non-linear normalization and background correction in one-channel cDNA microarray studies. Bioinformatics 19, 825-833.
9. Engelmann, A., Speidel, D., Bornkamm, G.W., Deppert, W., and Stocking, C. (2008). Gadd45 beta is a pro-survival factor associated with stress-resistant tumors. Oncogene 27, 1429-1438.
10. Fritz, G., Just, I., and Kaina, B. (1999). Rho GTPases are overexpressed in human tumors. Int J Cancer 81, 682-687.
11. Fung, K.M., Samara, E.N., Wong, C., Metwalli, A., Krlin, R., Bane, B., et al. (2006). Increased expression of type 2 3alphahydroxysteroid dehydrogenase=type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma. Endocr Relat Cancer 13, 169-180.
12. Higashi, E., Fukami, T., Itoh, M., Kyo, S., Inoue, M., Yokoi, T., et al. (2007). Human CYP2A6 is induced by estrogen via estrogen receptor. Drug Metab Dispos 35, 1935-1941.
13. Hosack, D.A., Dennis, G., Jr., Sherman, B.T., Lane, H.C., and Lempicki, R.A. (2003). Identifying biological themes within lists of genes with EASE. Genome Biol 4, R70.
14. Iscan, M., Klaavuniemi, T., Coban, T., Kapucuoglu, N., Pelkonen, O., and Raunio, H. (2001). The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue. Breast Cancer Res Treat 70, 47-54.
15. Ise, R., Han, D., Takahashi, Y., Terasaka, S., Inoue, A., Tanji, M. et al. (2005). Expression profiling of the estrogen responsive genes in response to phytoestrogens using a customized DNA microarray. FEBS Lett 579, 1732-1740.
16. Kuiper, G.G., Lemmen, J.G., Carlsson, B., Corton, J.C., Safe, S.H., van Der Saag, P.T., et al. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252-4263.
17. Lee, S.W., Reimer, C.L., Fang, L., Iruela-Arispe, M.L., and Aaronson, S.A. (2000). Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression. Mol Cell Biol 20, 1723-1732.
18. Lerebours, F., Vacher, S., Andrieu, C., Espie, M., Marty, M., Lidereau, R., et al. (2008). NF-kappa B genes have a major role in inflammatory breast cancer. BMC Cancer 8, 41.
19. Lin, H.K., Steckelbroeck, S., Fung, K.M., Jones, A.N., and Penning, T.M. (2004). Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alphahydroxysteroid dehydrogenase=type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate. Steroids 69, 795-801.
20. Maggiolini, M., Bonofiglio, D., Marsico, S., Panno, M.L., Cenni, B., Picard, D., et al. (2001). Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol 60, 595-602.
21. Martinez, M.E., Thomson, C.A., and Smith-Warner, S.A. (2006). Soy and breast cancer: the controversy continues. J Natl Cancer Inst 98, 430-431.
22. Mastyugin, V., Aversa, E., Bonazzi, A., Vafaes, C., Mieyal, P., and Schwartzman, M.L. (1999). Hypoxia-induced production of 12-hydroxyeicosanoids in the corneal epithelium: involvement of a cytochrome P-4504B1 isoform. J Pharmacol Exp Ther 289, 1611-1619.
23. McCarty, M.F. (2006). Isoflavones made simple-genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. Med Hypotheses 66, 1093-1114.
24. Messina, M., McCaskill-Stevens, W., and Lampe, J.W. (2006). Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst 98, 1275-1284.
25. Nakajima, M. (2007). Smoking behavior and related cancers: the role of CYP2A6 polymorphisms. Curr Opin Mol Ther 9, 538-544.
26. Remontet, L., Esteve, J., Bouvier, A.M., Grosclaude, P., Launoy, G., Menegoz, F., et al. (2003). Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 51, 3-30. (Pubitemid 36813955)
27. Rice, S., and Whitehead, S.A. (2006). Phytoestrogens and breast cancer-promoters or protectors? Endocr Relat Cancer 13, 995-1015.
28. Satih, S., Rabiau, N., Bignon, Y.J., and Bernard-Gallon, D. (2008). Soy phytoestrogens and breast cancer chemoprevention: molecular mechanisms. Curr Nutr Food Sci 4, 259-264.
29. Seta, F., Patil, K., Bellner, L., Mezentsev, A., Kemp, R., Dunn, M.W., et al. (2007). Inhibition of VEGF expression and corneal neovascularization by siRNA targeting cytochrome P450 4B1. Prostaglandins Other Lipid Mediat 84, 116-127.
30. Sirtori, C.R., Arnoldi, A., and Johnson, S.K. (2005). Phytoestrogens: end of a tale? Ann Med 37, 423-438.
31. Soule, H.D., Vazguez, J., Long, A., Albert, S., and Brennan, M. (1973). A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51, 1409-1416.
32. Soule, H.D., Maloney, T.M., Wolman, S.R., Peterson, W.D., Jr., Brenz, R., McGrath, C.M., et al. (1990). Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50, 6075-6086.
33. Trock, B.J., Hilakivi-Clarke, L., and Clarke, R. (2006). Metaanalysis of soy intake and breast cancer risk. J Natl Cancer Inst 98, 459-471.
34. Turner, D.P., Findlay, V.J., Kirven, A.D., Moussa, O., and Watson, D.K. (2008). Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression. Mol Biol Cell 19:3745-3757.
35. Tusher, V.G., Tibshirani, R., and Chu, G. (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98, 5116-5121.
36. Vissac-Sabatier, C., Bignon, Y.-J., and Bernard-Gallon, D.J. (2003). Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell lines. Nutr Cancer 45, 247-255.
37. Volak, L.P., Ghirmai, S., Cashman, J.R., and Court, M.H. (2008). Curcuminoids inhibit multiple human cytochromes P450, UDP- glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor. Drug Metab Dispos 36, 1594-1605.
38. Wagner, J., Jiang, L., and Lehmann, L. (2008). Phytoestrogens modulate the expression of 17alpha-estradiol metabolizing enzymes in culturedMCF-7 cells. Adv Exp Med Biol 617, 625-632.
39. Wettenhall, J.M., and Smyth, G.K. (2004). limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics 20, 3705-3706.
40. Wu, A.H., Yu, M.C., Tseng, C.C., and Pike, M.C. (2008). Epidemiology of soy exposures and breast cancer risk. Br J Cancer 98, 9-14.